CDH1 and cancer: However, the most recent ASCO guideline on GGT panels in patients with cancer proposes that when GGT is indicated for a patient with cancer, multigene panel testing should be offered if more than one gene is relevant, including BRCA1, BRCA2, PALB2, CDH1, PTEN, STK11, and TP53 genes (31).